Aurinia to Participate in Late Breaking Oral Presentations at Two Upcoming Scientific Conferences

VICTORIA, British Columbia–(BUSINESS WIRE)–Aurinia Pharmaceuticals Inc. (AUPH)(AUP.TO), a clinical stage biopharmaceutical company focused on the global immunology market, today announced that is has been selected to present late breaking oral presentations at both the 54th European Renal Association-European Dialysis and Transplant Association’s (ERA-EDTA) Congress and the Annual European Congress of Rheumatology (EULAR) 2017, on June 3th-6th, 2017, Madrid, Spain and June 14-17, Madrid, Spain, respectively.